Andelyn Biosciences AAV Curator Platform used to manufacture clinical grade viral vector for FDA-authorized first-in-world universal donor CRISPR/AAV transduced CAR-NK cells
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.